Calciphylaxis associated with the fibroblast growth factor receptor inhibitor erdafitinib

JAAD Case Rep. 2020 Dec 2:7:125-127. doi: 10.1016/j.jdcr.2020.11.022. eCollection 2021 Jan.

Authors

Paul Macklis¹, Catherine Chung^{2

3}, Benjamin Kaffenberger³

Affiliations

¹ The Ohio State University College of Medicine, Columbus, Ohio.
² Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, Ohio.
³ Department of Internal Medicine, Division of Dermatology, The Ohio State University Wexner Medical Center, Columbus, Ohio.

No abstract available

Keywords: FGFR inhibitors; FGFR, fibroblast growth factor receptor; calciphylaxis; drug reaction; hyperparathyroidism.

Publication types

Case Reports